SGRY Logo

SGRY Stock Forecast: Surgery Partners Inc. Price Predictions for 2025

Home โ€บ Stocks โ€บ United States | NASDAQ | Healthcare | Medical Care Facilities

$20.33

-2.84 (-12.26%)

SGRY Stock Forecast 2025-2026

$20.33
Current Price
$2.61B
Market Cap
12 Ratings
Buy 9
Hold 3
Sell 0
Wall St Analyst Ratings

Distance to SGRY Price Targets

+77.1%
To High Target of $36.00
+62.3%
To Median Target of $33.00
+18.1%
To Low Target of $24.00

SGRY Price Momentum

-12.0%
1 Week Change
-13.9%
1 Month Change
-18.8%
1 Year Change
-4.0%
Year-to-Date Change
-40.2%
From 52W High of $33.97
+4.3%
From 52W Low of $19.50
๐Ÿ“Š TOP ANALYST CALLS

Did SGRY Make This Month's Elite Buy List?

We don't follow just any analyst โ€” only the top 3% with a proven track record make our cut. See if Surgery Partners is one of their latest high-conviction picks.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Latest SGRY Stock Price Targets & Analyst Predictions

Based on our analysis of 19 Wall Street analysts, SGRY has a bullish consensus with a median price target of $33.00 (ranging from $24.00 to $36.00). The overall analyst rating is Strong Buy (8.8/10). Currently trading at $20.33, the median forecast implies a 62.3% upside. This outlook is supported by 9 Buy, 3 Hold, and 0 Sell ratings.

The most optimistic forecast comes from Jason Cassorla at Citigroup, projecting a 77.1% upside. Conversely, the most conservative target is provided by Andrew Mok at Barclays, suggesting a 18.1% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

SGRY Analyst Ratings

9
Buy
3
Hold
0
Sell

SGRY Price Target Range

Low
$24.00
Average
$33.00
High
$36.00
Current: $20.33

Latest SGRY Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for SGRY.

Date Firm Analyst Rating Change Price Target
May 27, 2025 Barclays Andrew Mok Equal-Weight Maintains $24.00
Apr 21, 2025 Benchmark Bill Sutherland Buy Reiterates $35.00
Mar 25, 2025 RBC Capital Ben Hendrix Outperform Reiterates $35.00
Mar 11, 2025 Macquarie Tao Qiu Outperform Maintains $33.00
Dec 3, 2024 JP Morgan Lisa Gill Neutral Maintains $28.00
Nov 20, 2024 RBC Capital Ben Hendrix Outperform Maintains $35.00
Nov 19, 2024 Macquarie Tao Qiu Outperform Maintains $34.00
Nov 13, 2024 Macquarie Tao Qiu Outperform Maintains $34.00
Nov 4, 2024 Macquarie Tao Qiu Outperform Maintains $35.00
Oct 14, 2024 UBS A.J. Rice Buy Initiates $38.00
Oct 11, 2024 Keybanc Matthew Gillmor Sector Weight Initiates $0.00
Oct 4, 2024 Cantor Fitzgerald Sarah James Overweight Reiterates $43.00
Aug 26, 2024 Benchmark Bill Sutherland Buy Reiterates $50.00
Aug 20, 2024 Cantor Fitzgerald Sarah James Overweight Reiterates $43.00
Aug 19, 2024 Cantor Fitzgerald Sarah James Overweight Reiterates $43.00
Aug 7, 2024 Citigroup Jason Cassorla Buy Maintains $36.00
Aug 7, 2024 RBC Capital Ben Hendrix Outperform Reiterates $49.00
Aug 7, 2024 Benchmark Bill Sutherland Buy Reiterates $50.00
Jul 10, 2024 Cantor Fitzgerald Sarah James Overweight Reiterates $43.00
Jul 9, 2024 Cantor Fitzgerald Sarah James Overweight Reiterates $43.00

Surgery Partners Inc. (SGRY) Competitors

The following stocks are similar to Surgery Partners based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Surgery Partners Inc. (SGRY) Financial Data

Surgery Partners Inc. has a market capitalization of $2.61B with a P/E ratio of 2,956.0x. The company generates $3.17B in trailing twelve-month revenue with a -6.1% profit margin.

Revenue growth is +8.2% quarter-over-quarter, while maintaining an operating margin of +11.5% and return on equity of -0.3%.

Valuation Metrics

Market Cap $2.61B
Enterprise Value $8.08B
P/E Ratio 2,956.0x
PEG Ratio 16.1x
Price/Sales 0.8x

Growth & Margins

Revenue Growth (YoY) +8.2%
Gross Margin +20.9%
Operating Margin +11.5%
Net Margin -6.1%
EPS Growth +8.2%

Financial Health

Cash/Price Ratio +8.9%
Current Ratio 1.9x
Debt/Equity 108.0x
ROE -0.3%
ROA +4.0%
๐Ÿ’ก SKIP THE NOISE

97% of Analyst Ratings Go Nowhere

We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ€” tracked and updated every Monday and Thursday.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Surgery Partners Inc. logo

Surgery Partners Inc. (SGRY) Business Model

About Surgery Partners Inc.

What They Do

Provides surgical services through outpatient facilities.

Business Model

The company operates a network of ambulatory surgical centers, hospitals, and physician practices, focusing on outpatient surgical procedures. It generates revenue by delivering high-quality surgical care and leveraging partnerships with healthcare practitioners to enhance service offerings.

Additional Information

Surgery Partners Inc. is positioned in the growing outpatient care sector, which is increasingly preferred for its cost-effectiveness and specialized care. The company's emphasis on advanced medical technologies and broad surgical disciplines ensures it meets evolving healthcare demands while maintaining a strong market presence.

Company Information

Sector

Healthcare

Industry

Medical Care Facilities

Employees

15,000

CEO

Mr. J. Eric Evans

Country

United States

IPO Year

2015

Surgery Partners Inc. (SGRY) Latest News & Analysis

Latest News

SGRY stock latest news image
Quick Summary

Surgery Partners, Inc. will hold its Q1 2025 Earnings Conference Call on May 12, 2025, at 8:30 AM ET, featuring CEO Eric Evans and CFO David Doherty.

Why It Matters

The upcoming earnings call for Surgery Partners provides crucial insights into the company's financial health and future outlook, influencing stock performance and investor sentiment.

Source: Seeking Alpha
Market Sentiment: Neutral
SGRY stock latest news image
Quick Summary

Surgery Partners, Inc. (NASDAQ: SGRY) announced its first-quarter results for 2025, ending March 31. Further financial details are pending release.

Why It Matters

Surgery Partners' Q1 results may impact stock performance and investor sentiment, indicating operational efficiency and potential growth in the competitive healthcare sector.

Source: GlobeNewsWire
Market Sentiment: Neutral
SGRY stock latest news image
Quick Summary

Surgery Partners (SGRY) reported Q3 earnings of $0.04 per share, missing the Zacks estimate of $0.08 and down from $0.10 per share year-over-year.

Why It Matters

Surgery Partners' earnings miss signals potential operational challenges, which may lead to decreased investor confidence and impact stock performance negatively.

Source: Zacks Investment Research
Market Sentiment: Negative
SGRY stock latest news image
Quick Summary

Advanced Aesthetics Plastic Surgery has partnered with Ascend Aesthetic Partners, adding three new physicians and expanding to 24 doctors across six states to enhance aesthetic medicine collaboration.

Why It Matters

The partnership enhances Ascend Aesthetic Partners' market presence and expertise, potentially increasing revenue and attracting investors focused on the growing aesthetic medicine sector.

Source: GlobeNewsWire
Market Sentiment: Neutral
SGRY stock latest news image
Quick Summary

Surgery Partners, Inc. (NASDAQ:SGRY) will release Q1 2025 results on May 12, 2025, before market opens, followed by a conference call at 8:30 a.m. ET.

Why It Matters

The scheduled earnings release and conference call will provide insights into Surgery Partners' financial health and operational performance, influencing investor sentiment and stock price.

Source: GlobeNewsWire
Market Sentiment: Neutral
SGRY stock latest news image
Quick Summary

Surgery Partners, Inc. (NASDAQ:SGRY) will hold its Q4 2024 earnings conference call on March 3, 2025, at 8:30 AM ET, featuring key executives and analysts from major financial firms.

Why It Matters

The upcoming earnings call for Surgery Partners could reveal key financial metrics and strategic insights, impacting stock performance and investor sentiment.

Source: Seeking Alpha
Market Sentiment: Neutral

Frequently Asked Questions About SGRY Stock

What is Surgery Partners Inc.'s (SGRY) stock forecast for 2025?

Based on our analysis of 19 Wall Street analysts, Surgery Partners Inc. (SGRY) has a median price target of $33.00. The highest price target is $36.00 and the lowest is $24.00.

Is SGRY stock a good investment in 2025?

According to current analyst ratings, SGRY has 9 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $20.33. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for SGRY stock?

Wall Street analysts predict SGRY stock could reach $33.00 in the next 12 months. This represents a 62.3% increase from the current price of $20.33. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Surgery Partners Inc.'s business model?

The company operates a network of ambulatory surgical centers, hospitals, and physician practices, focusing on outpatient surgical procedures. It generates revenue by delivering high-quality surgical care and leveraging partnerships with healthcare practitioners to enhance service offerings.

What is the highest forecasted price for SGRY Surgery Partners Inc.?

The highest price target for SGRY is $36.00 from Jason Cassorla at Citigroup, which represents a 77.1% increase from the current price of $20.33.

What is the lowest forecasted price for SGRY Surgery Partners Inc.?

The lowest price target for SGRY is $24.00 from Andrew Mok at Barclays, which represents a 18.1% increase from the current price of $20.33.

What is the overall SGRY consensus from analysts for Surgery Partners Inc.?

The overall analyst consensus for SGRY is bullish. Out of 19 Wall Street analysts, 9 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $33.00.

How accurate are SGRY stock price projections?

Stock price projections, including those for Surgery Partners Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: June 18, 2025 4:18 PM UTC
Serious About Growing Your Portfolio?

We highlight 2 high-upside stocks each month – no fluff.

Missed GME or NVDA? Donโ€™t Miss the Next One.โ€‹

Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ€” for free.